Meet Our Urologists
Mark P. Schoenberg, MD
|Medical Education:||University of Texas Medical School at Houston|
|Residency:||Hospital of the University of Pennsylvania|
|Fellowship:||Johns Hopkins Medical Center|
Adult Urology: 718-920-4531
Click here to see our locations
|Administrative Title:||University Professor & Chairman|
The treatment of patients with all forms of bladder cancer, with a particular interest in the care of patients with muscle-invasive tumors of the bladder.
Past research focused on the translational validation of urinary markers for the early detection of cancer, the development of regenerative medicine solutions to challenges of lower urinary tract reconstruction after bladder removal surgery, and the development of minimally invasive therapies for urologic malignancies.
Mark Schoenberg, MD, is a distinguished leader in the field of urology. He received his medical degree from the University of Texas Health Sciences Center. He completed his residency in general surgery and urology at the Hospital of the University of Pennsylvania, where he served as chief resident and urology instructor. He completed basic research and clinical urologic oncology fellowships at Johns Hopkins Hospital under the auspices of the American Cancer Society.
Prior to joining Montefiore in 2014, Dr. Schoenberg served as Director of Urologic Oncology and Bernard L. Schwartz Distinguished Professor of Urology at Johns Hopkins Hospital. During his 20-year tenure at Johns Hopkins, his clinical practice and research focused on the care of patients with all forms of bladder cancer.
Dr. Schoenberg is an active scholar, writer and editor. He is a past chair of the Medical Advisory Board of the Bladder Cancer Advocacy Network, author of The Guide to Living with Bladder Cancer, co-editor of The Textbook of Bladder Cancer, a contributor to Campbell's Urology and a seminars editor of the journal Urologic Oncology. He is a fellow of the American College of Surgeons, as well as a member of the American Association of Cancer Research, the Society of Urologic Oncology and the American Urological Association.